Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
Top Cited Papers
- 26 August 2007
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 25 (9) , 1015-1024
- https://doi.org/10.1038/nbt1327
Abstract
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.Keywords
This publication has 69 references indexed in Scilit:
- Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune responseThe FASEB Journal, 2007
- Cellular Cardiomyoplasty: Improvement of Left Ventricular Function Correlates with the Release of Cardioactive CytokinesThe International Journal of Cell Cloning, 2006
- Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarctionProceedings of the National Academy of Sciences, 2006
- Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell deathNature, 2005
- Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell deathNature, 2005
- Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the GraftCell Transplantation, 2005
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003
- Stem Cell BioengineeringAnnual Review of Biomedical Engineering, 2001
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998
- The speed of healing of myocardial infarctionAmerican Heart Journal, 1939